A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
Clinical trial NCT05911958 · RECRUITING
Trial details
- NCT number
- NCT05911958
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2024-12-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.